Esketamine is a prescription medication approved for certain adults with treatment-resistant depression and other FDA-cleared indications. Unlike many traditional antidepressants that primarily target serotonin, esketamine acts on the brain’s glutamate system, which plays an important role in mood regulation and communication between nerve cells.
Spravato® (esketamine) is administered as a nasal spray under direct medical supervision in a certified healthcare setting. Because of specific safety requirements, patients cannot take the medication at home. Instead, treatment takes place in a REMS-certified clinic where licensed healthcare professionals monitor patients throughout the appointment.
Furthermore, providers evaluate every patient individually before recommending treatment because depression affects each person differently.
Who May Benefit From Esketamine Depression Treatment?
Licensed psychiatric providers perform comprehensive evaluations to determine whether esketamine treatment is appropriate. Adults may be considered for treatment if they:
- Have treatment-resistant depression.
- Continue experiencing symptoms despite previous antidepressant therapy.
- Participate in ongoing psychiatric care.
- Can attend supervised in-office treatment appointments.
- Meet clinical eligibility requirements after evaluation.
Additionally, providers review each patient’s medical history, current medications, and treatment goals before making recommendations.
Because every individual’s circumstances are different, treatment decisions always reflect personalized clinical assessments rather than a standardized approach.
How Esketamine Treatment Works
Esketamine treatment begins with a comprehensive psychiatric evaluation. After confirming eligibility, providers develop an individualized treatment plan based on the patient’s symptoms and overall mental health needs.
During each treatment appointment:
- Patients self-administer the nasal spray under direct medical supervision.
- Licensed clinicians monitor patients throughout the visit.
- Patients remain under observation for at least two hours after treatment.
- Providers assess treatment response during follow-up appointments.
Moreover, patients should arrange transportation home after each appointment because they should not drive until the following day after a restful night’s sleep.
The Importance of Comprehensive Mental Health Care
Although Esketamine may become an important part of treatment, providers typically recommend combining medication with additional behavioral health services.
Depending on each patient’s needs, treatment plans may include:
- Individual therapy
- Medication management
- Psychiatric follow-up appointments
- Telehealth mental health services
- Lifestyle and wellness recommendations
As a result, patients receive coordinated care that addresses both immediate symptoms and emotional well-being.
Potential Benefits of Esketamine Depression Treatment
Treatment outcomes vary among individuals. However, some adults may experience:
- Improvement in depressive symptoms
- Greater participation in therapy
- Better daily functioning
- Improved emotional well-being
- Increased engagement in work, family, and personal activities
Furthermore, ongoing psychiatric monitoring allows providers to evaluate progress and adjust treatment recommendations when clinically appropriate.
Safety and Possible Side Effects
Esketamine treatment occurs only in REMS-certified healthcare settings under medical supervision. Therefore, trained clinicians monitor patients before, during, and after treatment to promote safety and address any concerns.
Some patients may experience temporary side effects, including:
- Dizziness
- Nausea
- Sleepiness
- Headache
- Temporary dissociation
- Increased blood pressure shortly after treatment
Before treatment begins, providers discuss potential benefits, risks, and expectations. Additionally, patients receive instructions about post-treatment care and follow-up appointments.
Why Choose SNBCare for Esketamine Depression Treatment?
SNBCare provides comprehensive outpatient mental health services for adults throughout Massachusetts and Rhode Island. Our experienced clinicians develop individualized treatment plans using evidence-informed practices while emphasizing compassionate, patient-centered care.
Our services include:
- Comprehensive psychiatric evaluations
- REMS-compliant Spravato® (esketamine) treatment
- Individual therapy
- Medication management
- Telehealth mental health services
- Ongoing psychiatric monitoring
Additionally, our providers work closely with patients throughout their treatment journey while maintaining HIPAA-compliant privacy and confidentiality.
Frequently Asked Questions
What is esketamine depression treatment?
Esketamine treatment is a prescription option for eligible adults with treatment-resistant depression and certain other approved indications. Licensed providers determine eligibility through a comprehensive psychiatric evaluation.
Is esketamine the same as ketamine?
No. Esketamine is a prescription medication derived from ketamine and is approved for specific clinical uses. It is administered only in REMS-certified healthcare settings under medical supervision.
Can I use esketamine at home?
No. Spravato® (esketamine) must be administered in a certified healthcare setting where licensed providers monitor patients throughout treatment.
How quickly does treatment work?
Every individual responds differently. Some adults may notice improvement sooner than with traditional antidepressants, while others require additional time and ongoing monitoring. Your provider will evaluate your progress throughout treatment.
Does insurance cover esketamine treatment?
Insurance coverage varies by plan and clinical eligibility. SNBCare can help patients understand their benefits and discuss available coverage options.
Accessing Esketamine Depression Treatment
Adults searching online for “esketamine depression,” “Spravato treatment near me,” or “treatment-resistant depression treatment” can begin with a comprehensive psychiatric evaluation at SNBCare. Following the evaluation, providers determine whether esketamine treatment is clinically appropriate and develop a personalized care plan that supports each patient’s mental health goals.
To learn more about esketamine depression treatment or schedule an appointment, visit SNBCare or call 781-666-2711.
Disclaimer
This content is provided for informational purposes only and should not replace professional medical advice, diagnosis, or treatment. SNBCare provides outpatient behavioral health services for adults in Massachusetts and Rhode Island. Spravato® (esketamine) is available only by prescription and must be administered in a REMS-certified healthcare setting under the supervision of licensed healthcare professionals. Treatment recommendations are based on individualized clinical evaluations.